Author

Divya Beri

Indian Institute of Science BangaloreORCID 0000-0002-5966-419XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Annapoorni RangarajaniD· 1 shared Armin GandhiiD· 1 shared Dharma PallyiD· 1 shared Paturu KondaiahiD· 1 shared Ramray BhatiD· 1 shared Rekha V. KumariD· 1 shared Sathish Manjunath· 1 shared Sharadhi Humcha· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Annapoorni RangarajanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJul 11, 2025

Stromal LOX/FAK/beta catenin pathway locks mammary fibroblasts into a tumor-promoting myCAF state

Armin Gandhi, Divya Beri, Dharma Pally…·Paturu Kondaiah

This study identifies LOX as a key mediator of TGF-β-induced myCAF state in breast cancer, showing its role in promoting tumor growth through a LOX/FAK/GSK3β/β-catenin pathway.

DOI 10.1101/2025.07.11.664481

humanbulk RNA-seq

𝕏 PostBluesky